Cargando…
The detection and prevention of adverse drug events in nursing home and home care patients: Study protocol of a quasi‐experimental study
AIM: To estimate the cost‐effectiveness of an intervention facilitating the early detection of adverse drug events through the means of health professional training and the application of a digital screening tool. DESIGN: Multi‐centred non‐randomized controlled trial from August 2018 to March 2020 i...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859083/ https://www.ncbi.nlm.nih.gov/pubmed/34859616 http://dx.doi.org/10.1002/nop2.1146 |
_version_ | 1784654374281150464 |
---|---|
author | Langenberger, Benedikt Baier, Natalie Hanke, Frank‐Christian Fahrentholz, Jacqueline Gorny, Christina Sehlen, Stephanie Reber, Katrin Christiane Liersch, Sebastian Radomski, Ralf Haftenberger, Jens Heppner, Hans Jürgen Busse, Reinhard Vogt, Verena |
author_facet | Langenberger, Benedikt Baier, Natalie Hanke, Frank‐Christian Fahrentholz, Jacqueline Gorny, Christina Sehlen, Stephanie Reber, Katrin Christiane Liersch, Sebastian Radomski, Ralf Haftenberger, Jens Heppner, Hans Jürgen Busse, Reinhard Vogt, Verena |
author_sort | Langenberger, Benedikt |
collection | PubMed |
description | AIM: To estimate the cost‐effectiveness of an intervention facilitating the early detection of adverse drug events through the means of health professional training and the application of a digital screening tool. DESIGN: Multi‐centred non‐randomized controlled trial from August 2018 to March 2020 including 65 nursing homes or home care providers. METHODS: We aim to estimate the effect of the intervention on the rate of adverse drug events as primary outcome through a quasi‐experimental empirical study design. As secondary outcomes, we use hospital admissions and falls. All outcomes will be measured on patient‐month level. Once the causal effect of the intervention is estimated, cost‐effectiveness will be calculated. For cost‐effectiveness, we include all patient costs observed by the German statutory health insurance. RESULTS: The results of this study will inform about the cost‐effectiveness of the optimized drug supply intervention and provide evidence for potential reimbursement within the German statutory health insurance system. |
format | Online Article Text |
id | pubmed-8859083 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88590832022-03-31 The detection and prevention of adverse drug events in nursing home and home care patients: Study protocol of a quasi‐experimental study Langenberger, Benedikt Baier, Natalie Hanke, Frank‐Christian Fahrentholz, Jacqueline Gorny, Christina Sehlen, Stephanie Reber, Katrin Christiane Liersch, Sebastian Radomski, Ralf Haftenberger, Jens Heppner, Hans Jürgen Busse, Reinhard Vogt, Verena Nurs Open Study Protocol AIM: To estimate the cost‐effectiveness of an intervention facilitating the early detection of adverse drug events through the means of health professional training and the application of a digital screening tool. DESIGN: Multi‐centred non‐randomized controlled trial from August 2018 to March 2020 including 65 nursing homes or home care providers. METHODS: We aim to estimate the effect of the intervention on the rate of adverse drug events as primary outcome through a quasi‐experimental empirical study design. As secondary outcomes, we use hospital admissions and falls. All outcomes will be measured on patient‐month level. Once the causal effect of the intervention is estimated, cost‐effectiveness will be calculated. For cost‐effectiveness, we include all patient costs observed by the German statutory health insurance. RESULTS: The results of this study will inform about the cost‐effectiveness of the optimized drug supply intervention and provide evidence for potential reimbursement within the German statutory health insurance system. John Wiley and Sons Inc. 2021-12-02 /pmc/articles/PMC8859083/ /pubmed/34859616 http://dx.doi.org/10.1002/nop2.1146 Text en © 2021 The Authors. Nursing Open published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Study Protocol Langenberger, Benedikt Baier, Natalie Hanke, Frank‐Christian Fahrentholz, Jacqueline Gorny, Christina Sehlen, Stephanie Reber, Katrin Christiane Liersch, Sebastian Radomski, Ralf Haftenberger, Jens Heppner, Hans Jürgen Busse, Reinhard Vogt, Verena The detection and prevention of adverse drug events in nursing home and home care patients: Study protocol of a quasi‐experimental study |
title | The detection and prevention of adverse drug events in nursing home and home care patients: Study protocol of a quasi‐experimental study |
title_full | The detection and prevention of adverse drug events in nursing home and home care patients: Study protocol of a quasi‐experimental study |
title_fullStr | The detection and prevention of adverse drug events in nursing home and home care patients: Study protocol of a quasi‐experimental study |
title_full_unstemmed | The detection and prevention of adverse drug events in nursing home and home care patients: Study protocol of a quasi‐experimental study |
title_short | The detection and prevention of adverse drug events in nursing home and home care patients: Study protocol of a quasi‐experimental study |
title_sort | detection and prevention of adverse drug events in nursing home and home care patients: study protocol of a quasi‐experimental study |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859083/ https://www.ncbi.nlm.nih.gov/pubmed/34859616 http://dx.doi.org/10.1002/nop2.1146 |
work_keys_str_mv | AT langenbergerbenedikt thedetectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy AT baiernatalie thedetectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy AT hankefrankchristian thedetectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy AT fahrentholzjacqueline thedetectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy AT gornychristina thedetectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy AT sehlenstephanie thedetectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy AT reberkatrinchristiane thedetectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy AT lierschsebastian thedetectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy AT radomskiralf thedetectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy AT haftenbergerjens thedetectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy AT heppnerhansjurgen thedetectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy AT bussereinhard thedetectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy AT vogtverena thedetectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy AT langenbergerbenedikt detectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy AT baiernatalie detectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy AT hankefrankchristian detectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy AT fahrentholzjacqueline detectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy AT gornychristina detectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy AT sehlenstephanie detectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy AT reberkatrinchristiane detectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy AT lierschsebastian detectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy AT radomskiralf detectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy AT haftenbergerjens detectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy AT heppnerhansjurgen detectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy AT bussereinhard detectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy AT vogtverena detectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy |